Lataa...
Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria
BACKGROUND: Chronic spontaneous/idiopathic urticaria (CSU/CIU) has substantial detrimental effects on health‐related quality of life (HRQoL) with an effect comparable to or worse than many other skin diseases. OBJECTIVE: To assess the effect of omalizumab on CSU patients' HRQoL, measured by the...
Tallennettuna:
| Julkaisussa: | J Eur Acad Dermatol Venereol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697571/ https://ncbi.nlm.nih.gov/pubmed/28573683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.14384 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|